January 9, 2017
TORONTO, January 9, 2017 – Jim Keon, President of Biosimilars Canada, issued the following statement regarding the release of the revised Guidance Document, Information and Submission Requirements for Biosimilar Biologic Drugs:
Read more
April 7, 2015
Toronto, April 7, 2015 – The Canadian Generic Pharmaceutical Association (CGPA) announced today the establishment of a new CGPA Biosimilars Board and the election of Michel Robidoux, President and General Manager of Sandoz Canada, as its inaugural Chair.
Read more